期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Column agglutination technology in immunologic diagnosis of haemolytic disease of the newborn.
1
《中国输血杂志》 CAS CSCD 2001年第S1期380-,共1页
关键词 Column agglutination technology in immunologic diagnosis of haemolytic disease of the newborn
下载PDF
Investigation of hemolytic disease of the newborn in Macao
2
《中国输血杂志》 CAS CSCD 2001年第S1期362-,共1页
关键词 Investigation of hemolytic disease of the newborn in Macao
下载PDF
Clinical Observation of Treatment of Hyperbilirubinemia in the Newborn by Integrated Traditional Chinese and Western Medicine
3
作者 孟浦 赵萍 +1 位作者 周东风 夏传雄 《Chinese Journal of Integrative Medicine》 SCIE CAS 2002年第2期115-117,共3页
Objective: To find a method of treatment for correcting hyperbilirubinemia timely and effectively to prevent bilirubin induced cerebral damage in the newborn. Methods: The newborns with hyperbilirubinemia in the ... Objective: To find a method of treatment for correcting hyperbilirubinemia timely and effectively to prevent bilirubin induced cerebral damage in the newborn. Methods: The newborns with hyperbilirubinemia in the treated group were treated with conventional treatment plus Butyribacterial preparation (BBP) and Simo Decoction (SMD, 四磨饮) taken orally, and the effect was compared with that in control group A treated with conventional treatment only and that in control group B treated with conventional treatment plus BBP. Results: The mean daily decreasing rate of bilirubin in the treated group was 51.11±25.03 μmol/L, which was higher than that in control groups A (39.36±22.44 μmol/L) and B (43.24±24.18 μmol/L), respectively ( P <0.01 and P <0.05). The bilirubin decreasing value on the first day and the speed of bilirubin decreasing (to 102.6 μmol/L) in the treated group were both higher than those in the control groups, P <0.01. Conclusion: The combined therapy of conventional treatment plus BBP and SMD could rapidly reduce the blood bilirubin level in the newborn with hyperbilirubinemia, and shorten the therapeutic course markedly, and the therapeutic effect is superior to that of the conventional treatment alone or that of the conventional treatment plus BBP only. 展开更多
关键词 hyperbilirubinemia in the newborn Butyribacterium Simo Decoction
原文传递
Effects of Different Modes of Labor Analgesia on Neonatal Neurobehavior
4
作者 Yu Han Qiu Meng +7 位作者 Zhuojiu Du Lianfang Chen Xianmei Wei Peijia Wei Xiaohua Huang Biyun Zhou Xiangli Feng Haiyan Lin 《Open Journal of Anesthesiology》 2021年第12期369-377,共9页
The term “painless delivery” originated from foreign countries and has a history of more than 100 years. It is actually called “childbirth analgesia” in medicine. Labor analgesia, as its name implies, is the use o... The term “painless delivery” originated from foreign countries and has a history of more than 100 years. It is actually called “childbirth analgesia” in medicine. Labor analgesia, as its name implies, is the use of various methods to reduce or even eliminate the pain during labor. With the development of anesthesiology and pain, it has been widely used in foreign countries, especially in some developed countries in the West. The rate of labor analgesia in the United States is > 85%, and even as high as 90% in Britain. The best childbirth analgesia should include side effect is small to puerpera and fetus, exact analgesic effect, quick effect, maintain time is long, can satisfy normal labor course;puerpera is awake, can cooperate childbirth and do not affect uterine contraction, and do not affect labor course progress. In 2000, WHO proposed that medical institutions should provide various labor analgesic services for parturient women to reduce labor pain as much as possible. Encourage the use of non-pharmaceutical analgesic techniques. In this paper, the effects of different modes of labor analgesia on neonates are described as follows. 展开更多
关键词 Painless Delivery Labor Analgesia the newborn Factors Nerve
下载PDF
Fetal Growth Restriction: Mechanisms, Epidemiology, and Management 被引量:2
5
作者 Hester D.Kamphof Selina Posthuma +1 位作者 Sanne J.Gordijn Wessel Ganzevoort 《Maternal-Fetal Medicine》 2022年第3期186-196,共11页
Fetal growth restriction(FGR)is the condition in which a fetus does not reach its intrinsic growth potential and in which the shortterm and long-term risks of severe complications are increased.FGR is a frequent compl... Fetal growth restriction(FGR)is the condition in which a fetus does not reach its intrinsic growth potential and in which the shortterm and long-term risks of severe complications are increased.FGR is a frequent complication of pregnancy with a complex etiology and limited management options,other than timely delivery.The most common pathophysiological mechanism is placental insufficiency,due to many underlying causes such as maternal vascular malperfusion,fetal vascular malperfusion and villitis.Identifying truly growth restricted fetuses remains challenging.To date,FGR is often defined by a cut-off of the estimated fetal weight below a certain percentile on a population-based standard.However,small fetal size as a single marker does not discriminate adequately between fetuses or newborns that are constitutionally small but healthy and fetuses or newborns that are growth restricted and thus at risk for adverse outcomes.In 2016,the consensus definition of FGR was internationally accepted to better pinpoint the FGR population.In this review we will discuss the contemporary diagnosis and management issues.Different diagnostic markers are considered,like Doppler measurements,estimated fetal growth,interval growth,fetal movements,biomarkers,and placental markers. 展开更多
关键词 Fetal growth restriction Growth restriction in the newborn Placental insufficiency syndrome Doppler measurements Biomarkers Placental function
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部